Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Clarent Biopharma, Inc.

Clinical trials sponsored by Clarent Biopharma, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New daily pill aims to tame psoriatic arthritis symptoms Results expected Feb 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Not yet recruiting 1 Completed 1

New daily pill aims to tame psoriatic arthritis symptoms

Disease control Not yet recruiting

This phase 2 trial tests an experimental oral drug called CBP-0276 in adults with active psoriatic arthritis, a condition causing joint pain, swelling, and skin plaques. Participants receive either a low dose (200 mg), a high dose (800 mg), or a placebo daily for 24 weeks. The ma…

Phase 2 • Sponsor: Clarent Biopharma, Inc. • Aim: Disease control

Last updated Jul 18, 2026 00:00 UTC